Autoimmune and ANA: Understanding Antinuclear Antibody Testing

Key takeaways

• The ANA test detects autoantibodies that target components of the cell nucleus, and it is commonly used as a screening test for suspected autoimmune disease.
• A positive ANA result is not a diagnosis. Many healthy people, especially women and older adults, have a positive ANA without any autoimmune disease.
• A negative ANA result makes certain autoimmune conditions, such as systemic lupus erythematosus, less likely but does not rule out all autoimmune diseases.
• ANA results are interpreted alongside symptoms, physical examination, and sometimes additional, more specific autoantibody tests.
• The pattern and titer of an ANA result can provide clues, but they must be evaluated by a clinician in the context of the whole patient.

What the ANA Test Measures

Antinuclear antibodies are proteins produced by the immune system that bind to parts of the cell nucleus, such as DNA, histones, and other nuclear proteins. In a healthy immune system, antibodies target foreign invaders like bacteria and viruses. In autoimmune conditions, the immune system can mistakenly produce antibodies against the body's own tissues. The ANA test detects the presence and amount of these antinuclear antibodies in a blood sample.

Laboratories typically use an indirect immunofluorescence assay, in which a sample of the patient's blood is applied to specially prepared cells on a slide. If antinuclear antibodies are present, they bind to the cell nuclei and are detected with a fluorescent marker. Some laboratories use other methods, such as enzyme-linked immunosorbent assays. The test result usually includes whether it is positive or negative, a titer that reflects how much the sample had to be diluted before antibodies were no longer detected, and sometimes a staining pattern.

When and Why an ANA Test Is Ordered

A healthcare provider may order an ANA test when a patient has signs or symptoms that could suggest an autoimmune disease. These can include unexplained joint pain or swelling, persistent fatigue, skin rashes, prolonged fever, hair loss, mouth ulcers, or symptoms involving multiple organ systems. The test is often used as an initial screening step because it is sensitive, meaning it is usually positive in many people who have certain autoimmune conditions.

The ANA test is most strongly associated with systemic lupus erythematosus, but it can also be positive in other conditions such as Sjogren's syndrome, scleroderma, mixed connective tissue disease, and some forms of autoimmune hepatitis. It can also be positive in people with thyroid disease, certain infections, and some medication exposures. Because of this broad overlap, the test is rarely useful on its own and is best ordered when there is a specific clinical question to answer.

How to Interpret ANA Results

A positive ANA result does not mean a person has an autoimmune disease. Studies cited by major health organizations indicate that a meaningful proportion of healthy individuals, particularly women and older adults, test positive without any underlying illness. This is why a positive result must always be considered together with the patient's symptoms, medical history, and physical examination findings. A negative result, meanwhile, makes conditions like systemic lupus erythematosus less likely, since most people with that condition have a positive ANA.

When an ANA is positive and the clinical picture is suspicious, providers may order more specific tests. These can include anti-double-stranded DNA, anti-Smith, anti-Ro, anti-La, anti-Scl-70, or anti-centromere antibodies, depending on the symptoms. The titer and pattern reported by the laboratory can offer additional clues, but they are not diagnostic by themselves. A high titer in someone with no symptoms may not require treatment, while a low titer in someone with classic symptoms may still prompt further evaluation.

Limitations and Practical Considerations

The ANA test has important limitations. It is sensitive but not specific, meaning it can be positive in many conditions and in healthy people. Ordering it without a clear clinical reason can lead to unnecessary anxiety, additional testing, and sometimes inappropriate referrals. Guidelines from rheumatology organizations generally advise against using ANA as a general screening test in people without symptoms or signs of autoimmune disease.

Test results can also vary between laboratories because of differences in methods, reagents, and reporting thresholds. A titer that is considered positive at one laboratory may be reported differently at another. If a patient changes providers or laboratories, it can be helpful to compare results with the reference ranges provided. Ultimately, the value of an ANA test depends on how it is used: as one piece of evidence within a careful clinical evaluation, not as a stand-alone answer.

Frequently Asked Questions

Sources

• MedlinePlus: Antinuclear Antibody Panel
• National Institute of Arthritis and Musculoskeletal and Skin Diseases: Lupus
• Centers for Disease Control and Prevention: Lupus
• Mayo Clinic: Antinuclear Antibody Test
• National Library of Medicine: Autoimmune Diseases